Search Within

Michael Morris

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (44)
  2. Meeting Abstract (19)
  3. Review (5)
  4. Book Section (1)
  5. Guidelines (1)
Groups
  1. Department of Medicine (70)
  2. Genitourinary Oncology Service (70)
  3. Sloan Kettering Institute Postdocs (70)
  4. Solid Tumor Oncology Division (70)
  5. GSK Faculty (50)
  6. Radiology, Department of (44)

More Groups

People
  1. Howard Scher (42)
  2. Wassim Abida (25)
  3. Daniel Danila (22)
  4. Philip Kantoff (20)
  5. Dana Rathkopf (18)
  6. Anuradha Gopalan (17)

More People

Years
  1. 2025 (3)
  2. 2024 (3)
  3. 2023 (8)
  4. 2022 (13)
  5. 2021 (8)
  6. 2020 (7)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Journal of Nuclear Medicine (11)
  3. Clinical Cancer Research (7)
  4. Cancer Research (4)
  5. European Urology (3)
  6. JCO Precision Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (17)
  2. American Association for Cancer Research (11)
  3. Society of Nuclear Medicine (11)
  4. Elsevier Inc. (4)
  5. Elsevier Science, Inc. (4)
  6. Cell Press (3)

More Publishers

Results (70)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways
    Journal Article

    Hirani, R.; Nandakumar, S.; Zaman, N.; Prabhakaraalva, P.; King, S. A.; Kalidindi, T. M.; Ghale, R.; Rajanala, S. H.; Fidele, D. C.; De Stanchina, E.; more...
    Cell Reports (2025)

    Fulltext@MSK | Save
  • Clinical, imaging, and technical factors associated with successful genomic profiling of bone biopsy tissue in prostate cancer
    Journal Article

    Ridouani, F.; Vargas, H. A.; Holzwanger, D. J.; Schöder, H.; Waters, E.; Petre, E. N.; Martin, A.; Satagopan, J.; Gonen, M.; Autio, K. A.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • Germline DNA damage repair variants and prognosis of patients with high-risk or metastatic prostate cancer
    Journal Article

    Stopsack, K. H.; Vijai, J.; Conry, M.; Berchuck, J. E.; Kemel, Y.; Vasselman, S. E.; Freeman, D. A.; Lee, G. S. M.; Mandelker, D.; Solit, D. B.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Microsatellite instability, tumor mutational burden, and response to immune checkpoint blockade in patients with prostate cancer
    Journal Article

    Lenis, A. T.; Ravichandran, V.; Brown, S.; Alam, S. M.; Katims, A.; Truong, H.; Reisz, P. A.; Vasselman, S.; Nweji, B.; Autio, K. A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: A phase 1/2, first-in-human trial
    Journal Article

    Tendler, S.; Dunphy, M. P.; Agee, M.; O'Donoghue, J.; Aly, R. G.; Choudhury, N. J.; Kesner, A.; Kirov, A.; Mauguen, A.; Baine, M. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen–targeted therapies
    Journal Article

    Zaidi, S.; Park, J.; Chan, J. M.; Roudier, M. P.; Zhao, J. L.; Gopalan, A.; Wadosky, K. M.; Patel, R. A.; Sayar, E.; Karthaus, W. R.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2024)

    Fulltext@MSK | Save
  • Case study #8: Alpha-therapy with radium-223 dichloride for metastatic castration-resistant prostate cancer
    Book Section

    Pasquini, L.; Morris, M. J.; Bodei, L.
    In Bodei, L.; Lewis, J. S.; Zeglis, B. M. (Eds.) Radiopharmaceutical Therapy (2023)

    Fulltext@MSK | Save
  • Evaluating immune-related adverse events using PRO-CTCAE in a phase II study of ipilimumab for hormone-sensitive prostate cancer
    Journal Article

    Vargas P. de Almeida, D.; Anderson, J. M.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Abida, W.; Cohn, E. D.; Baser, R. E.; Scher, H. I.; Autio, K. A.
    Journal of Immunotherapy and Precision Oncology (2023)

    Fulltext@MSK | Save
  • A phase 1, open-label, dose-ascending study to evaluate the safety and tolerability of the therapeutic radiopharmaceutical (131)I-MIP-1095 for the treatment of metastatic castration-resistant prostate cancer
    Journal Article

    Laccetti, A. L.; Bodei, L.; O'Donoghue, J. A.; Weber, W. A.; Morris, M. J.
    Clinical Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • A pilot study of stereotactic body radiotherapy and (177)Lu-PSMA-617 for oligometastatic hormone sensitive prostate cancer
    Meeting Abstract

    Imber, B. S.; Bodei, L.; Humm, J.; Ionescu, A.; Wu, W.; Grkovski, M.; O'Donoghue, J.; Reddy, R. P.; Rimner, A.; Shasha, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save